Back to Search Start Over

Yield10 Bioscience Exercises Option to Finalize an Exclusive, Global Commercial License to Advanced Omega-3 Camelina Technology from Rothamsted Research

Source :
Global Data Point. October 19, 2023
Publication Year :
2023

Abstract

(GlobeNewswire) - Yield10 Bioscience, Inc. (Nasdaq:YTEN) (Yield10 or the Company), an agricultural bioscience company, today announced that the Company has exercised its option to finalize an exclusive global, commercial license [...]

Details

Language :
English
Database :
Gale General OneFile
Journal :
Global Data Point
Publication Type :
News
Accession number :
edsgcl.769473712